Overexpression of P‐glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of P‐glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL LABORATORY ANALYSIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-27
DOI
10.1002/jcla.23374
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
- (2018) Raquel Maia et al. MOLECULES
- Mechanisms of Primary and Secondary Resistance to Imatinib in Chronic Myeloid Leukemia
- (2017) Alfonso Quintás-Cardama et al. Cancer Control
- Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring
- (2016) Elias Jabbour et al. AMERICAN JOURNAL OF HEMATOLOGY
- European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
- (2016) J L Steegmann et al. LEUKEMIA
- ABCB1 Overexpression Is a Key Initiator of Resistance to Tyrosine Kinase Inhibitors in CML Cell Lines
- (2016) Laura N. Eadie et al. PLoS One
- MRP1 and P-glycoprotein expression assays would be useful in the additional detection of treatment non-responders in CML patients without ABL1 mutation
- (2015) Sang Hyuk Park et al. LEUKEMIA RESEARCH
- Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
- (2015) Renata Silva et al. PHARMACOLOGY & THERAPEUTICS
- MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy
- (2015) Andreas-Claudius Hoffmann et al. NEOPLASIA
- Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib
- (2014) B. Hanfstein et al. HAEMATOLOGICA
- Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study
- (2012) F J Giles et al. LEUKEMIA
- SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia
- (2011) N. Esposito et al. BLOOD
- Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells
- (2011) Xing-Xiang Peng et al. Chinese Journal of Cancer
- Monitoring molecular response in chronic myeloid leukemia
- (2010) Jorge Cortes et al. CANCER
- Characterization of an Asymmetric Occluded State of P-glycoprotein with Two Bound Nucleotides
- (2010) Alena Siarheyeva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chronic Myeloid Leukemia Patients Sensitive and Resistant to Imatinib Treatment Show Different Metabolic Responses
- (2010) Jiye A et al. PLoS One
- Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance
- (2009) D. Bixby et al. Hematology-American Society of Hematology Education Program
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More